NCT00137371View on ClinicalTrials.gov

Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis

PHASE3CompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

September 30, 2007

Conditions
Atrophic VaginitisAtrophyVaginitis
Interventions
DRUG

PVC (daily for 21 days, 7 days off)

DRUG

PVC (twice weekly)

Trial Locations (49)

15206

Pittsburgh

19104

Philadelphia

22903

Charlottesville

23502

Norfolk

27103

Winston-Salem

27514

Chapel Hill

30328

Atlanta

30901

Augusta

33066

Tampa

33186

Miami

33407

West Palm Beach

33709

St. Petersburg

34613

Brooksville

48084

Troy

60612

Chicago

63141

St Louis

68134

Omaha

70006

Metairie

73112

Oklahoma City

75006

Carrollton

75010

Carrollton

75093

Plano

75246

Dallas

76034

Colleyville

77030

Houston

80010

Aurora

85715

Tucson

90502

Torrance

92024

Encinitas

92108

San Diego

08901

New Brunswick

17822-2920

Danville

T2N 4L7

Calgary

V3K 3V9

Coquitlam

V3H 4H9

Langley

R3A 1M3

Winnipeg

R3A 1R9

Winnipeg

K7L 2V7

Kingston

K1H 7W9

Ottawa

M5C 1R6

Toronto

M5G 1Z5

Toronto

M9W 4L6

Toronto

H1T 1P6

Montréal

H2X 1N8

Montréal

H3M 3A9

Montreal

H9R 4S3

Pointe-Claire

G1L 3L5

Québec

G9N 2H6

Shawinigan

J1H 5N4

Sherbrooke

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00137371 - Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis | Biotech Hunter | Biotech Hunter